113 related articles for article (PubMed ID: 2124180)
21. Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters.
Bulent Tiras M; Noyan V; Fener N; Guner H; Yildirim M; Darney PD
Contraception; 2001 Mar; 63(3):151-3. PubMed ID: 11368988
[TBL] [Abstract][Full Text] [Related]
22. Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate.
Howard G; Blair M; Fotherby K; Trayner I; Hamawi A; Elder MG
Lancet; 1982 Feb; 1(8269):423-5. PubMed ID: 6121092
[No Abstract] [Full Text] [Related]
23. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
Mink IB; Courey NG; Niswander KR; Moore RH; Lillie MA; Ambrus JL
Am J Obstet Gynecol; 1974 Jun; 119(3):401-5. PubMed ID: 4275088
[TBL] [Abstract][Full Text] [Related]
24. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata).
Shetty G; Krishnamurthy H; Krishnamurthy HN; Ramachandra SG; Moudgal NR
Contraception; 1997 Oct; 56(4):257-65. PubMed ID: 9408708
[TBL] [Abstract][Full Text] [Related]
25. Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive.
Schiavon R; Benavides S; Oropeza G; Garza-Flores J; Recio R; Díaz-Sanchez V; Pérez-Palacios G
Contraception; 1988 Jun; 37(6):591-8. PubMed ID: 3396358
[TBL] [Abstract][Full Text] [Related]
26. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
[TBL] [Abstract][Full Text] [Related]
27. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Furuhjelm M; Carlström K
Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
[TBL] [Abstract][Full Text] [Related]
28. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
Lechner K; Hartmann E; Schneider WH; Spona J; Matt K
Klin Wochenschr; 1976 May; 54(9):431-8. PubMed ID: 1271696
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive.
Recio R; Garza-Flores J; Schiavon R; Reyes A; Diaz-Sanchez V; Valles V; Luz de la Cruz D; Oropeza G; Perez-Palacios G
Contraception; 1986 Jun; 33(6):579-89. PubMed ID: 3769482
[TBL] [Abstract][Full Text] [Related]
30. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
Prasad RN; Koh S; Ratnam SS
Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
[TBL] [Abstract][Full Text] [Related]
31. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V
Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
[TBL] [Abstract][Full Text] [Related]
32. Assessment of a new low-dose once-a-month injectable contraceptive.
Garza-Flores J; Jimenez-Thomas S; Salomón-Andonie J; Díaz-Sanchez V
Contraception; 1988 May; 37(5):471-81. PubMed ID: 3409701
[TBL] [Abstract][Full Text] [Related]
33. Serum copper and zinc in hormonal contraceptive users.
Prema K; Ramalakshmi BA; Babu S
Fertil Steril; 1980 Mar; 33(3):267-71. PubMed ID: 6444895
[TBL] [Abstract][Full Text] [Related]
34. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
35. Long-term use of depot-norethisterone enanthate: effect on blood lipid fractions.
McEwan JA; Griffin M; Fotherby K; Trayner I
Contraception; 1992 Jul; 46(1):49-60. PubMed ID: 1424623
[TBL] [Abstract][Full Text] [Related]
36. Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation.
Yu AF; Wu SX; Liu JL; Liu AR; Li JZ; Wu JH; Hu ZZ; Yin BY; Xu GX; Fotherby K
Contraception; 1988 May; 37(5):517-28. PubMed ID: 2457468
[TBL] [Abstract][Full Text] [Related]
37. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
[TBL] [Abstract][Full Text] [Related]
38. Norethisterone contraceptive microspheres.
Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
[TBL] [Abstract][Full Text] [Related]
39. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
40. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
